Alona Muzikansky

Also affiliated with Revolution Research, Massachusetts General Hospital, Cancer Research And Biostatistics, Dana-Farber/Harvard Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Papers

Driven by 19 papers — median percentile 0. Top paper: “Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma”.

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2500

N/A

0.835DataRank · unranked

261 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-4084

N/A

0.574DataRank · unranked

45 citations

Ryan D. Gentzler, Sarah Clifford, Jill Kolesar, Alona Muzikansky, Eric B. Haura +15 more

Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study

Lung Cancer(2024)10.1016/j.lungcan.2024.108003

N/A

0.349DataRank · unranked

8 citations

Alissa J. Cooper, Bruce E. Johnson, Justin F. Gainor, W. Marston Linehan, Lecia V. Sequist +6 more

Real-time monitoring of mitochondrial oxygenation during machine perfusion using resonance Raman spectroscopy predicts organ function

Scientific Reports(2024)10.1038/s41598-024-57773-w

N/A

0.345DataRank · unranked

9 citations

Emmanuella O. Ajenu, Manuela Lopera Higuita, Ehab Hafiz, Alona Muzikansky, Padraic Romfh +2 more

Multi-center, single arm phase II study of the dual mTORC1/mTORC2 inhibitor vistusertib for patients with recurrent or progressive grade II-III meningiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2024

N/A

0.345DataRank · unranked

9 citations

Priya Kumthekar, Patrick Y. Wen, Frederick G. Barker, Anat Stemmer‐Rachamimov, Roberta L. Beauchamp +4 more

Co-Targeting IL-6 and EGFR signaling for the treatment of schwannomatosis and associated pain

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.06.527377

N/A

0.307DataRank · unranked

5 citations

Limeng Wu, Yanling Zhang, Yao Sun, John W. Chen, Sonu Subudhi +15 more

Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]

BMC Public Health(2022)10.1186/s12889-022-13631-w

N/A

0.229DataRank · unranked

3 citations

Autumn W. Rasmussen, Lynne I. Wagner, JoRean D. Sicks, Ilana F. Gareen, Ruth C. Carlos +17 more

Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.31.555783

N/A

0.104DataRank · unranked

1 citations

Zhenzhen Yin, Limeng Wu, Changli Yue, Yanling Zhang, Sonu Subudhi +7 more

Innovating CBT-I for cancer survivors: study protocol for a randomized controlled optimization trial

International Journal of Clinical Trials(2025)10.18203/2349-3259.ijct20251208

N/A

0DataRank · unranked

0 citations

Kelcie Willis, Caleb Bolden, Alona Muzikansky, Mark Gorman, Amy Comander +8 more

Non-invasive Resonance Raman Spectroscopy provides an early estimation of depth in a pig model of multi-depth burns

Research Square(2025)10.21203/rs.3.rs-6805519/v1

N/A

0DataRank · unranked

0 citations

Yanis Berkane, Emmanuella O. Ajenu, Khanh T. Nguyen, Austin Alana Shamlou, Alona Muzikansky +9 more

Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease

Nature Communications(2020)10.1038/s41467-020-16074-2

N/A

0DataRank · unranked

421 citations

Steven S. Hou, Austin Snyder, Elizabeth K. Kharitonova, Alyssa Russ, Sudeshna Das +7 more

Non-invasive Resonance Raman Spectroscopy provides an early estimation of depth in a pig model of multi-depth burns

Journal of Translational Medicine(2025)10.1186/s12967-025-07242-3

N/A

0DataRank · unranked

0 citations

Yanis Berkane, Emmanuella O. Ajenu, Khanh T. Nguyen, Austin Alana Shamlou, Alona Muzikansky +9 more

Cell release during perfusion reflects cold ischemic injury in rat livers

Scientific Reports(2020)10.1038/s41598-020-57589-4

N/A

0DataRank · unranked

20 citations

Casie A. Pendexter, Stephanie E. J. Cronin, Beatriz Marques, Ehab Hafiz, Alona Muzikansky +8 more

Isolation of intact extracellular vesicles from cryopreserved samples

PLoS ONE(2021)10.1371/journal.pone.0251290

N/A

0DataRank · unranked

19 citations

Lauren D. Bookstaver, Cindy Angpraseuth, Cleo J. Stannard, Beatriz Marques, Uyen Ho +7 more

Phase II Study of Cabozantinib in Patients With Bone Metastasis

The Oncologist(2022)10.1093/oncolo/oyac083

N/A

0DataRank · unranked

9 citations

Gregory A. Coté, M. Dror Michaelson, Lori J. Wirth, Justin F. Gainor, Alona Muzikansky +6 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168.v1

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Smoking cessation support and knowledge among newly diagnosed individuals at community cancer centers (ECOG-ACRIN trial EAQ171CD).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1522

N/A

0DataRank · unranked

0 citations

Jamie S. Ostroff, JoRean D. Sicks, Brett M. Goshe, Ilana F. Gareen, B. Herman +14 more

Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer

British Journal of Cancer(2024)10.1038/s41416-024-02863-9

N/A

0DataRank · unranked

16 citations

Zhenzhen Yin, Shuang Li, Limeng Wu, Yanling Zhang, Yanxia Zhao +9 more

Alona Muzikansky

Indexed papers

Top data-sharing exemplar

Papers